Newsbenzinga
China SXT Pharmaceuticals Announces Termination Of $12M Additional Purchase Right In Registered Direct Offering
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…